Literature DB >> 21502408

Chromatin in the nuclear landscape.

D B Beck1, R Bonasio, S Kaneko, G Li, G Li, R Margueron, H Oda, K Sarma, R J Sims, J Son, P Trojer, D Reinberg.   

Abstract

Chromatin affects many, if not all aspects, of nuclear organization and function. For this reason, we have focused our attention on elucidating some of the basic mechanisms regulating the formation and maintenance of chromatin, specifically concerning Polycomb repressive complex 2 (PRC2) and PR-Set7. PRC2 is responsible for catalyzing trimethylation of lysine 27 of histone H3 and thus has a critical role in the formation of facultative heterochromatin. PR-Set7 is responsible for catalyzing monomethylation of lysine 20 of histone H4 and is required for proper cell cycle progression and DNA damage response. We have also expanded our work to establish novel techniques and approaches to determine how chromatin is spatially regulated within the nuclear landscape.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502408      PMCID: PMC3832107          DOI: 10.1101/sqb.2010.75.052

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  76 in total

Review 1.  HP1 and the dynamics of heterochromatin maintenance.

Authors:  Christèle Maison; Geneviève Almouzni
Journal:  Nat Rev Mol Cell Biol       Date:  2004-04       Impact factor: 94.444

Review 2.  Chromosome territories--a functional nuclear landscape.

Authors:  Thomas Cremer; Marion Cremer; Steffen Dietzel; Stefan Müller; Irina Solovei; Stanislav Fakan
Journal:  Curr Opin Cell Biol       Date:  2006-05-09       Impact factor: 8.382

Review 3.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 4.  Facultative heterochromatin: is there a distinctive molecular signature?

Authors:  Patrick Trojer; Danny Reinberg
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

5.  Factors involved in specific transcription by mammalian RNA polymerase II. Identification and characterization of factor IIH.

Authors:  O Flores; H Lu; D Reinberg
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

Review 6.  The general transcription factors of RNA polymerase II.

Authors:  G Orphanides; T Lagrange; D Reinberg
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

7.  Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3.

Authors:  Tai-Lung Cha; Binhua P Zhou; Weiya Xia; Yadi Wu; Cheng-Chieh Yang; Chun-Te Chen; Bo Ping; Arie P Otte; Mien-Chie Hung
Journal:  Science       Date:  2005-10-14       Impact factor: 47.728

8.  The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans.

Authors:  Stuart S Levine; Alona Weiss; Hediye Erdjument-Bromage; Zhaohui Shao; Paul Tempst; Robert E Kingston
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.

Authors:  Alejandro Vaquero; Michael Scher; Hediye Erdjument-Bromage; Paul Tempst; Lourdes Serrano; Danny Reinberg
Journal:  Nature       Date:  2007-11-15       Impact factor: 49.962

Review 10.  MBT domain proteins in development and disease.

Authors:  Roberto Bonasio; Emilio Lecona; Danny Reinberg
Journal:  Semin Cell Dev Biol       Date:  2009-09-22       Impact factor: 7.727

View more
  12 in total

1.  Epigenetic modification of histone 3 lysine 27: mediator subunit MED25 is required for the dissociation of polycomb repressive complex 2 from the promoter of cytochrome P450 2C9.

Authors:  Neal A Englert; George Luo; Joyce A Goldstein; Sailesh Surapureddi
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

Review 2.  The origin and evolution of vertebrate sex chromosomes and dosage compensation.

Authors:  A M Livernois; J A M Graves; P D Waters
Journal:  Heredity (Edinb)       Date:  2011-11-16       Impact factor: 3.821

3.  PHF1 Tudor and N-terminal domains synergistically target partially unwrapped nucleosomes to increase DNA accessibility.

Authors:  Matthew D Gibson; Jovylyn Gatchalian; Andrew Slater; Tatiana G Kutateladze; Michael G Poirier
Journal:  Nucleic Acids Res       Date:  2017-04-20       Impact factor: 16.971

Review 4.  Chromatin-bound RNA and the neurobiology of psychiatric disease.

Authors:  J S Tushir; S Akbarian
Journal:  Neuroscience       Date:  2013-07-03       Impact factor: 3.590

Review 5.  Nuclear organization and genome function.

Authors:  Kevin Van Bortle; Victor G Corces
Journal:  Annu Rev Cell Dev Biol       Date:  2012-08-17       Impact factor: 13.827

6.  Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling.

Authors:  Hans-Martin Herz; Marc Morgan; Xin Gao; Jessica Jackson; Ryan Rickels; Selene K Swanson; Laurence Florens; Michael P Washburn; Joel C Eissenberg; Ali Shilatifard
Journal:  Science       Date:  2014-08-29       Impact factor: 47.728

7.  EZH2 regulates neuroepithelium structure and neuroblast proliferation by repressing p21.

Authors:  Naiara Akizu; María Alejandra García; Conchi Estarás; Raquel Fueyo; Carmen Badosa; Xavier de la Cruz; Marian A Martínez-Balbás
Journal:  Open Biol       Date:  2016-04-20       Impact factor: 6.411

8.  Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management.

Authors:  Allen S Ho; Sevin Turcan; Timothy A Chan
Journal:  Onco Targets Ther       Date:  2013-03-21       Impact factor: 4.147

9.  Mechanisms underlying epigenetic and transcriptional heterogeneity in Chinese hamster ovary (CHO) cell lines.

Authors:  Nathalie Veith; Holger Ziehr; Roderick A F MacLeod; Stella Marie Reamon-Buettner
Journal:  BMC Biotechnol       Date:  2016-01-22       Impact factor: 2.563

10.  Evidence for the association of chromatin and microRNA regulation in the human genome.

Authors:  Bang-Bao Tao; Xi-Qiang Liu; Wenhao Zhang; Shu Li; Dong Dong; Mang Xiao; Jun Zhong
Journal:  Oncotarget       Date:  2017-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.